Large Language Models (LLMs) are transforming patient education in medication management by providing accessible information to support healthcare decision-making. Building on our recent scoping review of LLMs in patient education, this perspective examines their specific role in medication guidance. These artificial intelligence (AI)-driven tools can generate comprehensive responses about drug interactions, side effects, and emergency care protocols, potentially enhancing patient autonomy in medication decisions. However, significant challenges exist, including the risk of misinformation and the complexity of providing accurate drug information without access to individual patient data. Safety concerns are particularly acute when patients rely solely on AI-generated advice for self-medication decisions. This perspective analyzes current capabilities, examines critical limitations, and raises questions regarding the possible integration of LLMs in medication guidance. We emphasize the need for regulatory oversight to ensure these tools serve as supplements to, rather than replacements for, professional healthcare guidance.